These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 19651008

  • 1. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [Abstract] [Full Text] [Related]

  • 2. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [Abstract] [Full Text] [Related]

  • 6. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE.
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI, Hinojosa Mena-Bernal C, del Pozo González J, del Pozo Pérez MA.
    Gastroenterol Hepatol; 2010 Apr; 33(6):425-32. PubMed ID: 20471720
    [Abstract] [Full Text] [Related]

  • 9. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [Abstract] [Full Text] [Related]

  • 10. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R, Vardar E, Demiri S, Sayhan SE, Bayol U, Yildiz C, Postaci H.
    Hepatogastroenterology; 2009 Sep; 56(94-95):1459-65. PubMed ID: 19950810
    [Abstract] [Full Text] [Related]

  • 11. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J.
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [Abstract] [Full Text] [Related]

  • 12. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM, Farid K, Emran TM, Attallah AA.
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [Abstract] [Full Text] [Related]

  • 13. Non-invasive models for predicting histology in patients with chronic hepatitis B.
    Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG.
    Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC, Liu CH, Lin CL, Wang PC, Tseng TC, Lin HH, Kao JH.
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [Abstract] [Full Text] [Related]

  • 16. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.
    Fabris C, Smirne C, Toniutto P, Colletta C, Rapetti R, Minisini R, Falleti E, Pirisi M.
    Clin Biochem; 2006 Apr; 39(4):339-43. PubMed ID: 16487951
    [Abstract] [Full Text] [Related]

  • 17. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.
    Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun SY, Park CK.
    Dig Liver Dis; 2008 Apr; 40(4):267-74. PubMed ID: 18055281
    [Abstract] [Full Text] [Related]

  • 18. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R, Ouzan D, Deydier R, Degott C, Halfon P.
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML.
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.